Serotonergic
One of 5 mechanistic pathways to 🌤️ Mood & stress resilience · 10 options
The most familiar pathway and the most oversold one. Serotonin is involved in mood, but the simple deficiency model has not survived scrutiny. The supplements here supply substrate or slow reuptake — and the interaction risk with prescription serotonergics is the single most important safety issue on this entire page.
Every substrate this pathway needs is testable, and three of them are commonly low. Correct those before layering a serotonergic on top — especially given the interaction risk if you are already on an SSRI.
Vitamin D (25-Hydroxy)FerritinVitamin B12Folate, SerumTSH (Thyroid-Stimulating Hormone)🧠 Mood, Anxiety & Low Motivation covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
🧬 L-5-HTP
One step from serotonin, bypassing the tryptophan hydroxylase bottleneck. Never combine with an SSRI, MAOI or tramadol — serotonin syndrome is a genuine and occasionally fatal risk. Peripheral conversion also means carbidopa is used in research settings for a reason.
🧬 L-Tryptophan
The upstream precursor, competing with other large neutral amino acids for transport — which is why it works better away from protein. Same interaction warnings apply.
🧬 Saffron
Several RCTs show efficacy comparable to low-dose SSRIs in mild-to-moderate depression. One of the genuinely surprising results in the botanical literature, and it has replicated.
🧬 St John's Wort
Well-established efficacy in mild-to-moderate depression and a serious CYP3A4 induction problem — it lowers levels of contraceptives, anticoagulants, transplant drugs and antiretrovirals. The interaction profile is the reason it is not first-line.
🧬 SAM-e
A universal methyl donor involved in monoamine synthesis. Trial evidence in depression is decent; it can trigger mania in bipolar illness and requires adequate B12 and folate to work.
🧬 Mood Support
A formulated blend targeting the pathway. Check components against your prescriptions before anything else.
🧬 Tianeptine
An atypical antidepressant that ENHANCES serotonin reuptake — the opposite of an SSRI — with real efficacy in European practice. It is also a mu-opioid agonist at higher doses, which has produced a genuine dependence problem. Approach with the seriousness that deserves.
💉 Trazodone
Serotonin antagonist and reuptake inhibitor. At low dose it is used almost entirely as a sleep agent; at antidepressant dose the sedation is limiting.
💉 NSI-189
Hippocampal neurogenesis rather than monoamine manipulation — a structurally different theory of depression.
💉 PE-22-28
TREK-1 channel blockade produces rapid antidepressant effects in animal models without touching monoamines.
What actually decides this outcome, in order of size
This is the only pathway on the site where the most important true statement is not about efficacy. Ranked by how much of the outcome each one owns:
- Whether anything here is going into a body that already contains a serotonergic drug. Serotonin syndrome is a real toxidrome with a described clinical picture and a described mechanism, and it is produced by combining agents rather than by any one of them Boyer 2005. The classes involved are ordinary: reuptake inhibitors, monoamine oxidase inhibitors, tramadol, linezolid, triptans, dextromethorphan, and the two substrate supplements at the top of this page. This outranks every efficacy question below it because the downside is asymmetric.
- Whether the deficiency model is the right frame at all, which is an open argument in print rather than a settled one. An umbrella review of the main areas of serotonin research reported no consistent evidence of an association between serotonin and depression Moncrieff 2022, and a rebuttal in the same journal argued that the umbrella missed the evidence that does exist Jauhar 2023. A goal page that tells you only one of those two is selling you a position.
- Severity, because the entire botanical evidence base sits in one band of it. The trials that support saffron, hypericum and S-adenosylmethionine were run in mild to moderate presentations, and clinician guidance for nutraceuticals in psychiatry is written for that band Sarris 2022. Nothing on this page has a trial base in severe or psychotic depression, and reading a mild-to-moderate result as a general one is the single commonest error made with this shelf.
- Whether substrate is actually the limiting step, which in most people it is not. Tryptophan hydroxylase, not tryptophan supply, sets the rate of serotonin synthesis, and the enzyme is regulated. That is the mechanistic reason a precursor can raise the substrate pool and leave the output where it was.
- The compounds, last, and the best-evidenced of them is a spice. A GRADE-assessed systematic review pooled 34 randomized controlled trials of saffron across depression, anxiety and mood disorder Mahmoudi 2026. Thirty-four trials is more replication than most of the prescription comparators on this page have for the same outcome, and it is still a botanical with heterogeneous extracts.
The order to run these in, and what has to be true first
Reconcile the prescriptions, exclude the four cheap medical imitators, then start with the most-replicated option rather than the most-marketed one. Running that backwards is how a reader adds a precursor to an existing prescription.
- List every prescription and every over-the-counter drug in the house, before buying anything. This step is free and it is the one that matters. The interaction is with the class, not with the brand, and the person to ask is the prescriber or pharmacist who holds the list. Nothing on this page substitutes for that conversation.
- One draw, to be normal. TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), because hypothyroidism reproduces low mood with fatigue and cold intolerance. Vitamin B12 and Folate, Serum, because both are cofactors for the methylation cycle that supplies the methyl groups monoamine synthesis runs on. Ferritin and Vitamin D (25-Hydroxy) complete the cheap exclusions. A normal set closes those questions for a year.
- Saffron first, on replication rather than on potency. Thirty-four randomized trials Mahmoudi 2026 is the strongest position on this shelf, and the crocin and safranal content of the extract is what was trialed rather than the weight of powder.
- SAM-e next, and only with B12 and folate already known. S-adenosylmethionine is the universal methyl donor, and a Cochrane review examined it for depression in adults Galizia 2016. It is regenerated through the methionine cycle, which is why B12 and folate status gate it, and it can destabilize mood in bipolar illness.
- St John's Wort is an efficacy question and a pharmacokinetic problem in one plant. Hyperforin induces CYP3A4 and P-glycoprotein, and the interaction list published for the plant covers contraceptives, anticoagulants, immunosuppressants and antiretrovirals Nobakht 2022. Induction takes days to build and days to wash out, so stopping it changes the exposure of everything else in the cupboard too.
- L-5-HTP and L-Tryptophan are substrate, and their pharmacokinetics are the argument against casual use. Oral 5-hydroxytryptophan has been studied in man at steady state Magnussen 1980, and it is decarboxylated in the periphery by aromatic L-amino acid decarboxylase before it reaches the brain, which is why research protocols pair it with a peripheral decarboxylase inhibitor and consumer products do not. Tryptophan competes with the other large neutral amino acids for the same transporter at the blood-brain barrier.
- Tianeptine and Trazodone are prescription pharmacology and belong to a prescriber. Tianeptine is a mu-opioid receptor agonist at supratherapeutic exposure, which is the mechanism behind the dependence and withdrawal reports attached to it. Trazodone is sedating at the doses people actually take it at.
- NSI-189 and PE-22-28 are a different theory of the same illness. Hippocampal neurogenesis and TREK-1 channel blockade are not monoamine mechanisms, and neither has an efficacy trial base that would justify placing it above the four options above it. Mood Support is judged on its components against the same list.
What gets bought for this that cannot move it
The category fails on measurement before it fails on efficacy. Nothing sold as raising serotonin can be checked in the person taking it. There is no clinical assay for brain serotonin. Platelet serotonin measures a platelet, urinary 5-HIAA is dominated by peripheral synthesis in enterochromaffin cells, and neither tracks central tone. That is why the umbrella review and its rebuttal are both arguing from indirect evidence Moncrieff 2022 Jauhar 2023 rather than from a number anybody can order.
5-HTP is the option on this page whose reputation most exceeds what it can be shown to do. Its safety record has been reviewed and the review is not alarming Das 2004, but the product category carries a specific historical scar: contaminants were identified in commercially available 5-hydroxytryptophan associated with eosinophilia-myalgia syndrome Klarskov 1999. Read that as a manufacturing argument for a certificate of analysis rather than as a verdict on the molecule, and read the peripheral decarboxylation problem as the reason a labeled milligram is not an exposure.
A trial in mild-to-moderate depression cannot be scaled up by increasing the dose. Severity changes the base rate of spontaneous improvement, which changes the size of the effect a trial can detect, which is why clinician guidance for this whole class is written with the severity band attached Sarris 2022. A reader who is severely unwell is not reading an under-dosed version of these trials. They are outside them.
And if the pattern does not fit, this is the wrong page. Wired and tired with an early-evening second wind is an axis question and routes to HPA axis & cortisol regulation. Low mood that tracks illness, gut trouble or a flare routes to Inflammation & the cytokine route to low mood. Anxiety without the anhedonia routes to GABAergic & calming. A B12, folate or homocysteine abnormality routes to Methylation & micronutrient substrate. Thoughts of self-harm are not a supplement question at any price and belong with a clinician today, not with a shelf.
How you would know it was working, on a real read-out and a real timescale
This page makes one prediction that can be wrong. If a serotonergic intervention is doing the work here, the symptom score should separate from placebo across a 6 to 8 week block, and the four exclusion markers should stay flat while it does. If the markers moved, they were the cause and the supplement was scenery.
- TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) once, at baseline. These exist here to be normal. Thyroid-driven low mood does not respond to a monoamine precursor, and the cost of finding that out at week 12 instead of week 0 is three months.
- Vitamin B12 and Folate, Serum with the same draw, and Homocysteine if either is borderline. Homocysteine is the functional read-out of the remethylation step, so it answers whether the cycle is actually running rather than whether the vitamins are present. It is also the marker that makes SAM-e a reasoned choice instead of a guess.
- Ferritin and Vitamin D (25-Hydroxy), once. Iron deficiency without anemia produces fatigue and low mood at a ferritin that a full blood count will not flag, and it is the commonest of the cheap imitators in menstruating adults.
- A validated symptom score, weekly, on the same day. The instrument matters less than the fixed cadence. Rating mood on the day you feel worst produces a curve that only goes up, which is a property of when you started measuring rather than of what you took.
- 8 weeks before a verdict, and the number has a reason. Antidepressant trials in this severity band are powered over 6 to 8 weeks because that is how long the separation from placebo takes to become detectable, not because 8 is a round number. Judging at 2 weeks measures expectancy.
What will fool you. Placebo response in mild-to-moderate depression trials is large, and mild episodes remit without treatment, so an uncontrolled personal trial that starts at the worst point will improve whatever you took. Season is the second confounder and it moves in the same direction over a winter-to-spring block. And a saffron extract standardized to its crocin content and a bag of culinary threads at the same labeled milligrams are not the same exposure, so a null result on the cheap version says nothing about the trials Mahmoudi 2026.
Sources read for these sections
- Boyer EW, Shannon M. The serotonin syndrome. New England Journal of Medicine 2005;352(11):1112-1120 · PMID 15784664
- Moncrieff J. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry 2022;27(8):3243-3256 · PMID 35854107
- Jauhar S. A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry 2023;28(8):3149-3152 · PMID 37322065
- Mahmoudi R. Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials. Nutritional Neuroscience 2026 · PMID 41693488
- Galizia I, Oldani L, et al. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database of Systematic Reviews 2016 · PMID 27727432
- Nobakht SZ. Hypericum perforatum: Traditional uses, clinical trials, and drug interactions. Iranian Journal of Basic Medical Sciences 2022;25(9):1045-1058 · PMID 36246064
- Sarris J. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World Journal of Biological Psychiatry 2022;23(6):424-455 · PMID 35311615
- Magnussen IE, Nielsen-Kudsk F. Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in steady state. Acta Pharmacologica et Toxicologica 1980;46(4):257-262 · PMID 6966118
- Klarskov K, et al. Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan. Advances in Experimental Medicine and Biology 1999;467:461-468 · PMID 10721089
- Das YT, et al. Safety of 5-hydroxy-L-tryptophan. Toxicology Letters 2004;150(1):111-122 · PMID 15068828
The other 4 routes to mood & stress resilience
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Mood & stress resilience Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Mood & stress resilience Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
The most familiar pathway and the most oversold one. Serotonin is involved in mood, but the simple deficiency model has not survived scrutiny. The supplements here supply substrate or slow reuptake — and the interaction risk with prescription serotonergics is the single most important safety issue on this entire page.
10 options are mapped to this pathway in the Vault, including L-5-HTP, L-Tryptophan, Saffron, St John's Wort. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 7 carry clinical validation and 3 are mechanistic predictions.
Every substrate this pathway needs is testable, and three of them are commonly low. Correct those before layering a serotonergic on top — especially given the interaction risk if you are already on an SSRI. The markers worth checking are Vitamin D (25-Hydroxy), Ferritin, Vitamin B12, Folate, Serum.
Unproven is not the same as ineffective. Of the 10 options on this pathway, 7 have clinical validation and 3 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Serotonergic. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.